Egetis Therapeutics 新闻与活动
在场
Egetis Therapeutics 是一家在股票代码 EGTX (SE) 下上市的公司。
高管
查看带有其 24 名主要高管的组织结构图
Egetis Therapeutics 搜索最多的简介
- Nicklas Westerholm, Chief Executive Officer
- Thomas Lönngren, Chairman of the Board
- Gunilla Osswald, Board Member
高管在Egetis Therapeutics变化
- Peder Walberg, Board Member, 已经离开公司 (新闻发布的2024十月6号).
创建提醒
跟踪 Egetis Therapeutics 的高管变动
生物技术
Egetis Therapeutics 拥有 2,347 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Genus (联合王国)。
Popular M&A news in 生物技术
- (公布2025三月28号).
- Epic-Bio 刚刚宣布为 68 筹款数百万美元。 (公布2025三月28号).
- Ernexa Therapeutics的新名称是Ernexa Therapeutics。 (公布2025三月26号).
生物技术 行业的其他推荐联系人
消息
Egetis Therapeutics 的最新新闻稿
- Issuance and repurchase of class C shares for incentive programs - Egetis Therapeutics
- Egetis receives positive CHMP opinion for Emcitate® (tiratricol) for the treatment of MCT8 deficiency - Egetis Therapeutics
- Egetis has decided to explore RTH-beta as the next indication for tiratricol (Emcitate®) - Egetis Therapeutics
- Save the Date: Egetis to host Investor Day on December 18, 2024 - Egetis Therapeutics
- Interim report Q3 2024 - Egetis Therapeutics
- Invitation to Presentation of Egetis’ Third Quarter 2024 Report - Egetis Therapeutics
- Change in the number of shares and votes in Egetis Therapeutics - Egetis Therapeutics
- Egetis’ Nomination Committee for the 2025 Annual General Meeting - Egetis Therapeutics
- Bulletin from Egetis Therapeutics’ Extraordinary General Meeting 2024 - Egetis Therapeutics
- Egetis Therapeutics publishes prospectus for admission to trading of shares on Nasdaq Stockholm - Egetis Therapeutics
- View more press releases Close
